Imad Hanna

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

Joe Bentz, Michael O′Connor, Dallas Bednarczyk et al. · Drug Metabolism and Disposition · 2013 · 147 citations · Full text

Expression of Human Cytochrome P450 2B6 in Escherichia coli: Characterization of Catalytic Activity and Expression Levels in Human Liver

Imad Hanna, James R. Reed, F. Peter Guengerich et al. · Archives of Biochemistry and Biophysics · 2000 · 111 citations

Expression Levels, Biosynthesis, Cellular Enzymology +12

Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli

Robert Vail, M J Homann, Imad Hanna et al. · Journal of Industrial Microbiology & Biotechnology · 2005 · 101 citations · Full text

Recombinant Human Cytochrome P450 1B1 Expression inEscherichia coli

Tsutomu Shimada, Rebecca M. Wunsch, Imad Hanna et al. · Archives of Biochemistry and Biophysics · 1998 · 90 citations · Full text

Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects

Sam Rebello, Sally Zhao, Sam Hariry et al. · European Journal of Clinical Pharmacology · 2011 · 66 citations

Nutrition, Healthy Subjects, Gastrointestinal Pharmacology +6